Biblio

Export 794 results:
Author Title Type [ Year(Asc)]
Filters: First Letter Of Last Name is V  [Clear All Filters]
2022
A. A. Diaz Baquero, Franco-Martín, M. A., Vidales, E. Parra, Toribio-Guzmán, J. Miguel, Bueno-Aguado, Y., Abad, F. Martínez, Bartolomé, M. V. Perea, Asl, A. Mahmoudi, and van der Roest, H. G., The Effectiveness of GRADIOR: A Neuropsychological Rehabilitation Program for People with Mild Cognitive Impairment and Mild Dementia. Results of a Randomized Controlled Trial After 4 and 12 Months of Treatment., J Alzheimers Dis, vol. 86, no. 2, pp. 711-727, 2022.
L. Clare, Martyr, A., Gamble, L. D., Pentecost, C., Collins, R., Dawson, E., Hunt, A., Parker, S., Allan, L., Burns, A., Hillman, A., Litherland, R., Quinn, C., Matthews, F. E., and Victor, C., Impact of COVID-19 on 'Living Well' with Mild-to-Moderate Dementia in the Community: Findings from the IDEAL Cohort., J Alzheimers Dis, vol. 85, no. 2, pp. 925-940, 2022.
J. Laton, Van Schependom, J., Goossens, J., Wiels, W., Sieben, A., De Deyn, P. Paul, Goeman, J., Streffer, J., van der Zee, J., Martin, J. - J., Van Broeckhoven, C., De Vos, M., Bjerke, M., Nagels, G., and Engelborghs, S., Improved Alzheimer's Disease versus Frontotemporal Lobar Degeneration Differential Diagnosis Combining EEG and Neurochemical Biomarkers: A Pilot Study., J Alzheimers Dis, vol. 90, no. 4, pp. 1739-1747, 2022.
J. Laton, Van Schependom, J., Goossens, J., Wiels, W., Sieben, A., De Deyn, P. Paul, Goeman, J., Streffer, J., van der Zee, J., Martin, J. - J., Van Broeckhoven, C., De Vos, M., Bjerke, M., Nagels, G., and Engelborghs, S., Improved Alzheimer's Disease versus Frontotemporal Lobar Degeneration Differential Diagnosis Combining EEG and Neurochemical Biomarkers: A Pilot Study., J Alzheimers Dis, vol. 90, no. 4, pp. 1739-1747, 2022.
J. Laton, Van Schependom, J., Goossens, J., Wiels, W., Sieben, A., De Deyn, P. Paul, Goeman, J., Streffer, J., van der Zee, J., Martin, J. - J., Van Broeckhoven, C., De Vos, M., Bjerke, M., Nagels, G., and Engelborghs, S., Improved Alzheimer's Disease versus Frontotemporal Lobar Degeneration Differential Diagnosis Combining EEG and Neurochemical Biomarkers: A Pilot Study., J Alzheimers Dis, vol. 90, no. 4, pp. 1739-1747, 2022.
Z. D. Green, Vidoni, E. D., Swerdlow, R. H., Burns, J. M., Morris, J. K., and Honea, R. A., Increased Functional Connectivity of the Precuneus in Individuals with a Family History of Alzheimer's Disease., J Alzheimers Dis, vol. 91, no. 2, pp. 559-571, 2022.
K. Wittfeld, Raman, M. R., Conner, S. C., Aslam, A., Teumer, A., Nauck, M., Hosten, N., Habes, M., DeCarli, C., Vasan, R. S., Beiser, A. S., Himali, J. J., Seshadri, S., Grabe, H. J., and Satizabal, C. L., Insulin-Like Growth Factor, Inflammation, and MRI Markers of Alzheimer's Disease in Predominantly Middle-Aged Adults., J Alzheimers Dis, vol. 88, no. 1, pp. 311-32, 2022.
A. Ticinesi, Mancabelli, L., Carnevali, L., Nouvenne, A., Meschi, T., Del Rio, D., Ventura, M., Sgoifo, A., and Angelino, D., Interaction Between Diet and Microbiota in the Pathophysiology of Alzheimer's Disease: Focus on Polyphenols and Dietary Fibers., J Alzheimers Dis, vol. 86, no. 3, pp. 961-982, 2022.
D. Castro Araújo, Veloso, A. Alonso, Gomes, K. Braga, de Souza, L. Cruz, Ziviani, N., and Caramelli, P., A Novel Panel of Plasma Proteins Predicts Progression in Prodromal Alzheimer's Disease., J Alzheimers Dis, vol. 88, no. 2, pp. 549-561, 2022.
F. Morys, Potvin, O., Zeighami, Y., Vogel, J., Lamontagne-Caron, R., Duchesne, S., and Dagher, A., Obesity-Associated Neurodegeneration Pattern Mimics Alzheimer's Disease in an Observational Cohort Study., J Alzheimers Dis, vol. 91, no. 3, pp. 1059-1071, 2022.
V. K. Ramanan, Heckman, M. G., Przybelski, S. A., Lesnick, T. G., Lowe, V. J., Graff-Radford, J., Mielke, M., Jack, C. R., Knopman, D. S., Petersen, R. C., Ross, O. A., and Vemuri, P., Polygenic Scores of Alzheimer's Disease Risk Genes Add Only Modestly to APOE in Explaining Variation in Amyloid PET Burden., J Alzheimers Dis, vol. 88, no. 4, pp. 1615-1625, 2022.
F. K. Kok, van Leerdam, S. L., and de Lange, E. C. M., Potential Mechanisms Underlying Resistance to Dementia in Non-Demented Individuals with Alzheimer's Disease Neuropathology., J Alzheimers Dis, vol. 87, no. 1, pp. 51-81, 2022.
S. Hendriks, Peetoom, K., Tange, H., van Bokhoven, M. A., van der Flier, W. M., Bakker, C., Papma, J. M., Koopmans, R., Verhey, F., Köhler, S., and de Vugt, M., Pre-Diagnostic Symptoms of Young-Onset Dementia in the General Practice up to Five Years Before Diagnosis., J Alzheimers Dis, vol. 88, no. 1, pp. 229-239, 2022.
S. Hendriks, Peetoom, K., Tange, H., van Bokhoven, M. A., van der Flier, W. M., Bakker, C., Papma, J. M., Koopmans, R., Verhey, F., Köhler, S., and de Vugt, M., Pre-Diagnostic Symptoms of Young-Onset Dementia in the General Practice up to Five Years Before Diagnosis., J Alzheimers Dis, vol. 88, no. 1, pp. 229-239, 2022.
S. Hendriks, Peetoom, K., Tange, H., van Bokhoven, M. A., van der Flier, W. M., Bakker, C., Papma, J. M., Koopmans, R., Verhey, F., Köhler, S., and de Vugt, M., Pre-Diagnostic Symptoms of Young-Onset Dementia in the General Practice up to Five Years Before Diagnosis., J Alzheimers Dis, vol. 88, no. 1, pp. 229-239, 2022.
D. J. Jester, Vyhnálek, M., Andel, R., Marková, H., Nikolai, T., Laczó, J., Matuskova, V., Cechova, K., Sheardova, K., and Hort, J., Progression from Subjective Cognitive Decline to Mild Cognitive Impairment or Dementia: The Role of Baseline Cognitive Performance., J Alzheimers Dis, vol. 86, no. 4, pp. 1763-1774, 2022.
S. E. O'Bryant, Zhang, F., Petersen, M., Hall, J. R., Johnson, L. A., Yaffe, K., Braskie, M., Vig, R., Toga, A. W., and Rissman, R. A., Proteomic Profiles of Neurodegeneration Among Mexican Americans and Non-Hispanic Whites in the HABS-HD Study., J Alzheimers Dis, vol. 86, no. 3, pp. 1243-1254, 2022.
E. Marina Gon Cordero, Cuevas-Budhart, M. Angel, Morán, D. Pérez, Villeda, M. Angel Trej, and Gª-Madrid, M. Gomez- Del-, Relationship Between the Gut Microbiota and Alzheimer's Disease: A Systematic Review., J Alzheimers Dis, vol. 87, no. 2, pp. 519-528, 2022.
M. Vassilaki, Crowson, C. S., Iii, J. M. Davis, Duong, S. Q., Jones, D. T., Nguyen, A., Mielke, M. M., Vemuri, P., and Myasoedova, E., Rheumatoid Arthritis, Cognitive Impairment, and Neuroimaging Biomarkers: Results from the Mayo Clinic Study of Aging., J Alzheimers Dis, vol. 89, no. 3, pp. 943-954, 2022.
M. Vassilaki, Crowson, C. S., Iii, J. M. Davis, Duong, S. Q., Jones, D. T., Nguyen, A., Mielke, M. M., Vemuri, P., and Myasoedova, E., Rheumatoid Arthritis, Cognitive Impairment, and Neuroimaging Biomarkers: Results from the Mayo Clinic Study of Aging., J Alzheimers Dis, vol. 89, no. 3, pp. 943-954, 2022.
E. Lacorte, Ancidoni, A., Zaccaria, V., Remoli, G., Tariciotti, L., Bellomo, G., Sciancalepore, F., Corbo, M., Lombardo, F. L., Bacigalupo, I., Canevelli, M., Piscopo, P., and Vanacore, N., Safety and Efficacy of Monoclonal Antibodies for Alzheimer's Disease: A Systematic Review and Meta-Analysis of Published and Unpublished Clinical Trials., J Alzheimers Dis, vol. 87, no. 1, pp. 101-129, 2022.
X. Hua, Church, K., Walker, W., L'Hostis, P., Viardot, G., Danjou, P., Hendrix, S., and Moebius, H. J., Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Positive Modulator of HGF/MET, Fosgonimeton, in Healthy Volunteers and Subjects with Alzheimer's Disease: Randomized, Placebo-Controlled, Double-Blind, Phase I Clinical Trial., J Alzheimers Dis, vol. 86, no. 3, pp. 1399-1413, 2022.
C. F. M. Huffels, van Dijk, R. E., Karst, H., Meye, F. J., Hol, E. M., and Middeldorp, J., Systemic Injection of Aged Blood Plasma in Adult C57BL/6 Mice Induces Neurophysiological Impairments in the Hippocampal CA1., J Alzheimers Dis, vol. 89, no. 1, pp. 283-297, 2022.
N. Krishnadas, Huang, K., Schultz, S. A., Doré, V., Bourgeat, P., M Y Goh, A., Lamb, F., Bozinovski, S., Burnham, S. C., Robertson, J. S., Laws, S. M., Maruff, P., Masters, C. L., Villemagne, V. L., and Rowe, C. C., Visually Identified Tau 18F-MK6240 PET Patterns in Symptomatic Alzheimer's Disease., J Alzheimers Dis, vol. 88, no. 4, pp. 1627-1637, 2022.

Pages